Breaking News
- BusinessTelecom pricing revival critical for long-term growth: KM Birla
- TravelA Pop-Up in Berlin will Explore Strategies for Tourism Recovery
- WorldTejashwi Yadav fires 10 questions at Nitish Kumar, gets one sharp comeback
- NigeriaYour hair defines your self worth – BO Hair CEO, Onuzurike Oluomachi
- SportsRaiders GM: Bowden trade ‘was a football decision,’ blames position change
- BusinessZap-Map launches ‘game-changing’ EV charging service
- NigeriaPandemic crumbles adult education, literacy rate likely to slow down
- TravelHow a crowdfunded travel guidebook could help protect Socotra island
- SportsInconsistency And Injuries Are Slowly Closing Window Of Opportunity For New York Yankees
- BusinessIs It Time for Investors to Ditch Their 401(k)s for Retirement?
Blueprint, Roche take on Lilly with FDA approval for RET cancer drug Gavreto
This post was originally published on this siteBlueprint Medicines and partner Roche have won FDA approval for RET inhibitor Gavreto to challenge Eli Lilly’s first-to-market Retevmo.
Read MoreRoche gets emergency approval for combination flu, COVID-19 test
This post was originally published on this siteRoche said Sept. 4 it has received emergency authorization from the FDA for its nasal swab test that detects the flu and COVID-19 and differentiates
Read MoreRoche receives US emergency approval for coronavirus vs. flu test
This post was originally published on this siteZURICH (Reuters) – Drugmaker Roche (ROG.S) on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug
Read MoreRegeneron’s Deal With Roche to Make Covid Antibody ‘Should Add Credibility to This Program’
This post was originally published on this siteRegeneron Pharmaceuticals announced a deal with rival drugmaker Roche Holding to manufacture Regeneron’s experimental Covid-19 antibody
Read MoreRoche and Regeneron Team Up on Covid-19 Antibody Treatment
This post was originally published on this siteHere’s what you need to know about the impact of Covid-19 to navigate the markets today. • Pharmaceutical companies Roche and Regeneron
Read MoreRegeneron enlists Roche to help make Covid-19 drug
This post was originally published on this siteRoche Holding AG has agreed to help manufacture and distribute a promising investigational drug for Covid-19 being developed by Regeneron
Read MoreRoche, Regeneron link up on COVID-19 antibody cocktail
This post was originally published on this siteZURICH (Reuters) – Regeneron and Roche said on Wednesday they will collaborate on an investigational antibody cocktail against COVID-19, with
Read MoreRoche’s Soliris rival Enspryng bags FDA approval
This post was originally published on this siteRoche’s neuromyelitis optica spectrum disorder (NMOSD) drug Enspryng has scored US Food and Drug Administration (FDA) approval, setting up a
Read MoreHits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
This post was originally published on this siteRoche’s batch of phase 3 tests of its experimental GI drug etrolizumab has not gone to plan, with “mixed results” highlighting a
Read MoreFDA approves Roche’s new spinal muscular atrophy drug
This post was originally published on this siteRoche Holding AG ROG, -0.27% said Friday that the Food and Drug Administration had approved Evrysdi, a treatment for spinal muscular atrophy in
Read More